Another study conducted on animals and patients with AF reported that miR-328 is aberrantly up-regulated and targets CACNA1C and CACNB1 in AF, which results in reduced ICaL activity and a shortage of APD [111]. This evidence concerns the gene CACNA1C and atrial fibrillation.